|Articles|January 28, 2020

EDAN Instruments Reveals Upgrades to Acclarix LX9 Ultrasound System

System and upgrades awaiting U.S. FDA clearance

DUBAI-China-based global healthcare company EDAN Instruments, Inc., unveiled its next-generation diagnostic ultrasound system Acclarix LX9 during Arab Health 2020.

The Acclarix LX9 system is currently awaiting 510(k) clearance from the U.S. Food and Drug Administration.

With Acclarix LX9, EDAN is adding artificial intelligence (AI) technologies to its existing ultrasound family. New features include eOB, eLV, eFollicle, eVolFlow, and eNT, all of which, according to Alice Bai, EDAN’s ultrasound clinical application manager, are designed to optimize workloads for sonographers in a various departments, such as obstetrics, gynecology, cardiology, and general surgery.

In addition to the additional AI features, LX9 also offers a 21.5-inch, high resolution LCD screen equipped with a new EIS+ platform that improves image quality. The integrated user interface can also be rotated 180 degrees.


Related to this article

Key Sessions of Interest for Radiologists at the Upcoming HLTH USA Conference
How will generative AI software be evaluated by the FDA in the future? What’s next for point-of-care ultrasound? What steps have been successful in facilitating adoption of AI applications across enterprise systems? Leaders in radiology and health care will be discussing these topics and more at the upcoming HLTH USA conference.